Prognostic role of controlling nutritional status score in hematological malignancies

Abstract

Background Controlling nutritional status (CONUT) score, based on three indexes including serum albumin (ALB), total cholesterol (CHO), and absolute lymphocyte count (ALC), has been closely associated with the prognosis of cancer patients. Multiple studies revealed the significance of CONUT score in hematological malignancies, including diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), multiple myeloma (MM), and leukemia.Objective This review aimed to explore the prognostic role of CONUT score in hematological malignancies.Methods We conducted this review through Pubmed to summarize the published studies on the CONUT score in hematological malignancies, using the terms: Controlling nutritional status, CONUT score, hematological malignancy, lymphoma, multiple myeloma, and leukemia.Result CONUT score can reflect not only the nutritional status but also the inflammatory status of patients with hematological malignancies. It can assist in predicting the survival of patients with DLBCL, PTCL, MM, adult T-cell leukemia (ATL), myelodysplastic syndrome (MDS), and acute myeloid leukemia with myelodysplasia related changes (AML-MRC).Conclusion CONUT score plays an important role in predicting the prognosis of patients with hematological malignancies.

Keywords

• Controlling nutritional status (CONUT) score
• hematological malignancies
• prognosis
• clinical outcome
• lymphoma
• multiple myeloma